BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global oncology company which intends to change its name to BeOne Medicines Ltd., today announced it has entered into a settlement agreement ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback